FDA Inspection 1221247 — Contract Pharmaceuticals Limited Canada

Contract Pharmaceuticals Limited Canada — FEI 3011158222

The FDA completed an inspection of Contract Pharmaceuticals Limited Canada on Sep 13, 2023 in Mississauga. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 13, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mississauga (Canada)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.